Business Context and Reporting Period
This Form 8-K, dated October 23, 2024, reports the consummation of the Initial Public Offering (IPO) by Oaktree Acquisition Corp. III Life Sciences, a Cayman Islands special purpose acquisition company (SPAC). The IPO was completed on October 25, 2024, following the effectiveness of the Registration Statement on October 23, 2024.
Key Financial Metrics
- Public Offering: Sold 17,500,000 Public Units at $10.00 per unit, generating gross proceeds of $175,000,000.
- Private Placement: Sold 550,000 Private Placement Units to the Sponsor at $10.00 per unit, generating $5,500,000 in proceeds.
- Over-Allotment Option: Underwriters hold a 45-day option to purchase up to 2,625,000 additional Public Units.
- Trust Account: Net proceeds from the IPO and certain private placement proceeds are held in a trust account managed by Continental Stock Transfer & Trust Company.
- Administrative Costs: The Sponsor provides administrative services for $25,000 per month until the initial business combination or liquidation.
Material Changes
The filing marks the transition of the Company from a pre-IPO entity to a publicly traded company on The Nasdaq Stock Market LLC. Key securities registered include Class A ordinary shares (OACC), Units (OACCU), and Redeemable Warrants (OACCW). The Company adopted an Amended and Restated Memorandum and Articles of Association effective October 23, 2024.
Outlook, Risks, and Agreements
- Business Combination Timeline: The Company has 24 months from the IPO date to consummate an initial business combination. If not achieved, the Company will liquidate.
- Warrant Terms: Warrants are exercisable for one Class A ordinary share at $11.50 per share. Private Placement Warrants are non-redeemable by the Company.
- Sponsor Commitments: The Sponsor and executive officers/directors agreed to vote in favor of the initial business combination and facilitate liquidation if the deadline is missed. The Sponsor also has the right to nominate three board members post-combination.
- Underwriters: Jefferies LLC, Citigroup Global Markets Inc., and UBS Securities LLC served as representatives.
Investor Verification Checklist
- Verify the final amount of funds deposited into the Trust Account after deducting underwriting discounts and offering expenses.
- Confirm the exercise of the underwriters' over-allotment option within the 45-day window.
- Review the specific redemption rights and liquidation preferences for Public Shares versus Private Placement Shares.
- Monitor the 24-month deadline for completing an initial business combination.
- Examine the full text of the Underwriting Agreement and Administrative Services Agreement for additional indemnification or liability clauses.